Personalized Medicine Market by Therapeutic Area (Oncology, Neurology, Cardiology, Antiviral, Psychiatry, and Others), by Application (Companion Diagnostics, Health Informatics, Biomarker Identification, and Clinical Research Applications), by End-User (Hospitals, Molecular Diagnostic Laboratories and Testing Facilities, Academic Institutes, Clinical Care and Research Laboratories, Contract Research Organizations, Bio and Health Informatics Companies, and Others), and by Technology (Pharmacogenomics, Metabolomics, Pharmacoproteomics, Pharmacogenetics, Stem Cell Therapy, Pharmacodynamics, Point of Care, and Pharmacokinetics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024

Global personalized medicine market expected to generate revenue of around USD 3466 million by 2024, growing at a CAGR of around 11.9% between 2018 and 2024. Personalized medicines, also known as individualized medicines or precision medicines, is an evolving field used by physicians where diagnostic tests are performed to identify the biological markers.

03-Dec-2018 | Number of pages: 110 | Report Code: ZMR-3583 | Report Format : | Status : Published

Analysis

Personalized medicine is tailored medical treatment for individual patients or intended patient groups with a similar biomarker. These medicines are manufactured to fulfill the requirements of individual patients according to their condition and patient response suffering from a particular disease. In personalized medicines, detailed information about patient genotype, gene expression level, and clinical data of patients are used to select proper medication, preventive measures, and therapy for individuals. These medicines have various benefits compared to conventional treatment methods, such as safety, high effectiveness, accuracy, and faster recovery. Personalized medicines are adopted by doctors on large-scale due to their effective treatment of various diseases, such as cancer, rare genetic disorders, etc.

With the emergence of advanced technology in the healthcare industry, there is an increase in the incidences of diseases, such as cancer, genetic disorders, etc.. Fast results, customized effects, and low probability of adverse reaction of these drugs are expected to contribute toward the increase in the revenue. Favorable government policies with respect to personalized medicine are expected to create opportunities for the personalized medicine market. Recent developments related to pharmacogenomics are expected to create a favorable environment for the under-development drugs that are specific to a patient or patient group. Increase in the genetic database and upcoming therapeutic application in different fields, such as neurology, pulmonary psychiatry are expected to drive the global personalized medicine market over the forecast time period. However, the complex nature of drugs and high development costs might hinder the expansion of personalized medicines in the future.

Global Personalized Medicine Market

By therapeutic area, the personalized medicine market is segmented into oncology, neurology, cardiology, antiviral, psychiatry, and others. By application, this market is segmented into biomarker identification, clinical research, companion diagnostics, and health informatics. By end-user, this market is segmented into contract research organizations, hospitals, bio and health informatics companies, molecular diagnostic laboratories and testing facilities, academic institutes, clinical care, and research laboratories, and others. By technology, the personalized medicine market includes pharmacogenomics, metabolomics, pharmacoproteomics, pharmacogenetics, stem cell therapy, pharmacodynamics, pharmacokinetics, and point of care.

North America is likely to dominate the global personalized medicine market during the forecast period, which would be closely followed by Europe. Increase in the healthcare expenditure and increased awareness are expected to drive these regional markets. The Asia Pacific is projected to be the third fastest growing region in the global personalized medicine market, due to the increase in the disease, rise in awareness, and increased healthcare expenditure over the forecast time period. The Middle East and Africa are anticipated to show moderate growth over the forecast time period.

Some key players of the global personalized medicine market include F. Hoffmann-La Roche Ltd., Pfizer Inc., Qiagen, AstraZeneca Plc., Merck & Co., Inc., Siemens Healthcare GmbH, Vertex Pharmaceuticals Incorporated, and Becton, Dickinson, and Company, among others.


Related Reports

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.